Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000872
Filing Date
2025-01-06
Accepted
2025-01-06 19:00:17
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01062025_070113.html 4  
1 form4-01062025_070113.xml 4 9128
  Complete submission text file 0001415889-25-000872.txt   10816
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150 SAN DIEGO CA 92121
Business Address
Auwaerter Paul Gisbert (Reporting) CIK: 0001982730 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 25512910